|
|
|
Constipation Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for
Constipation.
Please click "Search" to find Constipation clinical trials and medical research
studies or read below for information on Constipation diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 21 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Colonic Tube to Improve Bowel Function in Spinal Cord Injury - NCT00345397-53295
Conditions: Constipation - Fecal Incontinence - Spinal Cord Injury Location: Milwaukee, WI
- A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation - NCT01040637-78209
Conditions: Healthy - Opioid-induced Constipation Location: San Antonio, TX
- A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation - NCT01040637-84106
Conditions: Healthy - Opioid-induced Constipation Location: Salt Lake City, UT
- A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation - NCT01040637-91105
Conditions: Healthy - Opioid-induced Constipation Location: Pasadena, CA
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-27103
Conditions: Opioid-induced Constipation Location: Winston-Salem, NC
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-32734
Conditions: Opioid-induced Constipation Location: DeLand, FL
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-35660
Conditions: Opioid-induced Constipation Location: Sheffield, AL
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-70114
Conditions: Opioid-induced Constipation Location: New Orleans, LA
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-83704
Conditions: Opioid-induced Constipation Location: Boise, ID
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-84106
Conditions: Opioid-induced Constipation Location: Salt Lake City, UT
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-91105
Conditions: Opioid-induced Constipation Location: Pasadena, CA
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-92801
Conditions: Opioid-induced Constipation Location: Anaheim, CA
- A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation - NCT01100151-94598
Conditions: Opioid-induced Constipation Location: Walnut Creek, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-02135
Conditions: Irritable Bowel Syndrome Location: Boston, MA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-11214
Conditions: Irritable Bowel Syndrome Location: Brooklyn, NY
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-15206
Conditions: Irritable Bowel Syndrome Location: Pittsburgh, PA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-20707
Conditions: Irritable Bowel Syndrome Location: Laurel, MD
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-20815
Conditions: Irritable Bowel Syndrome Location: Chevy Chase, MD
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-27103
Conditions: Irritable Bowel Syndrome Location: Winston-Salem, NC
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-27262
Conditions: Irritable Bowel Syndrome Location: High Point, NC
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-27514
Conditions: Irritable Bowel Syndrome Location: Chapel Hill, NC
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-27612
Conditions: Irritable Bowel Syndrome Location: Raleigh, NC
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-30067
Conditions: Irritable Bowel Syndrome Location: Marietta, GA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-30189
Conditions: Irritable Bowel Syndrome Location: Woodstock, GA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-30328
Conditions: Irritable Bowel Syndrome Location: Atlanta, GA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-32129
Conditions: Irritable Bowel Syndrome Location: Port Orange, FL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-33155
Conditions: Irritable Bowel Syndrome Location: Miami, FL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-33458
Conditions: Irritable Bowel Syndrome Location: Jupiter, FL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-33486
Conditions: Irritable Bowel Syndrome Location: Boca Raton, FL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-33613
Conditions: Irritable Bowel Syndrome Location: Tampa, FL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-35215
Conditions: Irritable Bowel Syndrome Location: Birmingham, AL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-35801A
Conditions: Irritable Bowel Syndrome Location: Huntsville, AL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-35801B
Conditions: Irritable Bowel Syndrome Location: Huntsville, AL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-36617
Conditions: Irritable Bowel Syndrome Location: Mobile, AL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-37403
Conditions: Irritable Bowel Syndrome Location: Chattanooga, TN
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-37660
Conditions: Irritable Bowel Syndrome Location: Kingsport, TN
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-38301
Conditions: Irritable Bowel Syndrome Location: Jackson, TN
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-38305
Conditions: Irritable Bowel Syndrome Location: Jackson, TN
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-39202A
Conditions: Irritable Bowel Syndrome Location: Jackson, MS
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-39202B
Conditions: Irritable Bowel Syndrome Location: Jackson, MS
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-44122
Conditions: Irritable Bowel Syndrome Location: Cleveland, OH
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-45224
Conditions: Irritable Bowel Syndrome Location: Cincinnati, OH
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-45242
Conditions: Irritable Bowel Syndrome Location: Cincinnati, OH
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-45440
Conditions: Irritable Bowel Syndrome Location: Dayton, OH
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-46514
Conditions: Irritable Bowel Syndrome Location: Elkhart, IN
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-47714
Conditions: Irritable Bowel Syndrome Location: Evansville, IN
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-49079
Conditions: Irritable Bowel Syndrome Location: Paw Paw, MI
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-53186
Conditions: Irritable Bowel Syndrome Location: Waukesha, WI
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-53215
Conditions: Irritable Bowel Syndrome Location: Milwaukee, WI
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-61107
Conditions: Irritable Bowel Syndrome Location: Rockford, IL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-61602
Conditions: Irritable Bowel Syndrome Location: Peoria, IL
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-65265
Conditions: Irritable Bowel Syndrome Location: Mexico City, MO
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-66160
Conditions: Irritable Bowel Syndrome Location: Kansas City, KS
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-67203
Conditions: Irritable Bowel Syndrome Location: Wichita, KS
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-71103
Conditions: Irritable Bowel Syndrome Location: Shreveport, LA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-72120
Conditions: Irritable Bowel Syndrome Location: Sherwood, AR
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-75605
Conditions: Irritable Bowel Syndrome Location: Longview, TX
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-77030
Conditions: Irritable Bowel Syndrome Location: Houston, TX
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-80108
Conditions: Irritable Bowel Syndrome Location: Castle Rock, CO
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-83404
Conditions: Irritable Bowel Syndrome Location: Idaho Falls, ID
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-84405
Conditions: Irritable Bowel Syndrome Location: Ogden, UT
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-85381
Conditions: Irritable Bowel Syndrome Location: Peoria, AZ
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-85741
Conditions: Irritable Bowel Syndrome Location: Tucson, AZ
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-89014
Conditions: Irritable Bowel Syndrome Location: Henderson, NV
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-90211
Conditions: Irritable Bowel Syndrome Location: Beverly Hills, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-91361
Conditions: Irritable Bowel Syndrome Location: Westlake Village, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-92024
Conditions: Irritable Bowel Syndrome Location: Encinitas, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-92103
Conditions: Irritable Bowel Syndrome Location: San Diego, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-92108
Conditions: Irritable Bowel Syndrome Location: San Diego, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-92610
Conditions: Irritable Bowel Syndrome Location: Foothill Ranch, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-92691
Conditions: Irritable Bowel Syndrome Location: Mission Vejo, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-92840
Conditions: Irritable Bowel Syndrome Location: Garden Grove, CA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-98101
Conditions: Irritable Bowel Syndrome Location: Seattle, WA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-99207
Conditions: Irritable Bowel Syndrome Location: Spokane, WA
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females - NCT00547469-99216
Conditions: Irritable Bowel Syndrome Location: Spokane, WA
- AcuGraph and Digestive Symptoms - NCT00846794-63017
Conditions: Digestive Disorders - Irritable Bowel Syndrome - Constipation - Diarrhea Location: Chesterfield, MO
- Amitiza in Constipation Associated With PD (Parkinson's Disease) - NCT00908076-33606
Conditions: Parkinson's Disease Location: Tampa, FL
- Amitiza in Constipation Associated With PD (Parkinson's Disease) - NCT00908076-77030
Conditions: Parkinson's Disease Location: Houston, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-06010
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Bristol, CT
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-07712
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Ocean, NJ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-07927
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Cedar Knolls, NJ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-08053
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Marlton, NJ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-11501
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Mineola, NY
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-14534
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Pittsford, NY
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-15213
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Pittsburgh, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-17604
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lancaster, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-18960
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sellersville, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-19056
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Levittown, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-19606
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lancaster, PA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-20636
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Hollywood, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-20707
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Laurel, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-21215
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Baltimore, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-21401
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Annapolis, MD
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-23320
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chesapeake, VA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-24502
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lynchburg, VA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27103
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Winston Salem, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27203
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Asheboro, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27408
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Greensboro, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-27599
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chapel Hill, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28075
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Harrisburg, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28078
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Huntersville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28211
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Charlotte, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28401
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Wilmington, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28546
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jacksonville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28562
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: New Bern, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28602
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Hickory, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28625
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Statesville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-28801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Asheville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29414
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Charleston, SC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29485
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Summerville, NC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29621
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Anderson, SC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-29681
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Simpsonville, SC
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-30263
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Newnan, GA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-32129
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Port Orange, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-32205
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jacksonville, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-32256
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jacksonville, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33021
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Hollywood, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33156
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Miami, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33319
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lauderdale Lakes, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33426
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Boynton Beach, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33607
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tampa, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-33782
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Pinellas Park, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-34452
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Inverness, FL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-35209
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Birmingham, AL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-35801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Huntsville, AL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37203
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Nashville, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37421
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chattanooga, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37620
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Bristol, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-37660
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Kingsport, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-38138
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Germantown, TN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-38801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tupelo, MS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-39202
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jackson, MS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-43560
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sylvania, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-43701
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Zanesville, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-44060
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Mentor, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-44122
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Beachwood, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-44281
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Wadsworth, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-45224
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Cincinnati, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-45242
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Cincinnati, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-45440
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Dayton, OH
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-46011
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Anderson, IN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-48047
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chesterfield, MI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-48098
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Troy, MI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-49684
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Traverse City, MI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-50325
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Clive, IA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-52807
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Davenport, IA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-53215
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Milwaukee, WI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-54601
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Lacrosse, WI
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-55446
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Plymouth, MN
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-61602
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Peoria, IL
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-65109
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Jefferson City, MO
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-66202
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Mission, KS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-66215
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Overland Park, KS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-66606
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Topeka, KS
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-70006
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Metairie, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-70809
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Baton Rouge, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-71103
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Shreveport, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-71201
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Monroe, LA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-72120
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sherwood, AR
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-73099
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Yukon, OK
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-73116
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Oklahoma City, OK
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-75061
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Irving, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-75605
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Longview, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-76104
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Fort Worth, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-77024
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Houston, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-77479
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sugarland, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-77701
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Beaumont, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-78229
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Antonio, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-79905
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: El Paso, TX
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-80904
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Colorado Springs, CO
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-84107
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Salt Lake City, UT
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-84405
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Ogden, UT
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85020
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Phoenix, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85224
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chandler, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85710
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tuscon, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85715
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tucson, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-85741
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Tucson, AZ
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-87108
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Albuquerque, NM
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-89104
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Henderson, NV
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-89128
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Las Vegas, NV
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-90045
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Los Angeles, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-91910
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Chula Vista, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92024
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Encinitas, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92103
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Diego, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92108
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Diego, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92123
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Diego, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92653
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Laguna Hills, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92801
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Anaheim, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92840
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Garden Grove, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-92868
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Orange, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-94070
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: San Carlos, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-95830
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Sacramento, CA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-98664
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Vancouver, WA
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-99208
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation Location: Spokane, WA
- Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department? - NCT00949377-10003
Conditions: Constipation Location: New York, NY
- Colonic Transit Time Validation Study - NCT00857363-02114
Conditions: Constipation Location: Boston, MA
- Colonic Transit Time Validation Study - NCT00857363-14215
Conditions: Constipation Location: Buffalo, NY
- Colonic Transit Time Validation Study - NCT00857363-19140
Conditions: Constipation Location: Philadelphia, PA
- Colonic Transit Time Validation Study - NCT00857363-27157
Conditions: Constipation Location: Winston Salem, NC
- Colonic Transit Time Validation Study - NCT00857363-27516
Conditions: Constipation Location: Chapel Hill, NC
- Colonic Transit Time Validation Study - NCT00857363-48109
Conditions: Constipation Location: Ann Arbor, MI
- Colonic Transit Time Validation Study - NCT00857363-49007
Conditions: Constipation Location: Kalamazoo, MI
- Colonic Transit Time Validation Study - NCT00857363-52242
Conditions: Constipation Location: Iowa City, IA
- Colonic Transit Time Validation Study - NCT00857363-55905
Conditions: Constipation Location: Rochester, MN
- Colonic Transit Time Validation Study - NCT00857363-66160
Conditions: Constipation Location: Kansas City, KS
- Colonic Transit Time Validation Study - NCT00857363-85723
Conditions: Constipation Location: Tucson, AZ
- Colonic Transit Time Validation Study - NCT00857363-90048
Conditions: Constipation Location: Los Angeles, CA
- Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome - NCT00564707-20307
Conditions: Levator Ani Syndrome With Pain and/or Constipation Symptoms. Location: Washington, DC
- Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications - NCT01096290-36693
Conditions: Constipation Location: Mobile, AL
- Comparison Trial of Enema vs. PEG 3350 for Constipation - NCT00467350-64108
Conditions: Constipation Location: Kansas City, MO
- Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling - NCT00677508-53226
Conditions: Constipation - Fecal Incontinence Location: Milwaukee, WI
- Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen - NCT01003249-27157
Conditions: Overactive Bladder - Constipation - Lower Urinary Tract Symptoms Location: Winston-Salem, NC
- Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation - NCT01038687-55905
Conditions: Functional Constipation Location: Rochester, MN
- Effect of TU 100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation - NCT01139216-55905
Conditions: Functional Constipation - Gastric Emptying - Whole Gut Transit - Small Bowel Transit - Colonic Transit - Rectal Compliance - Rectal Sensation Location: Rochester, MN
- Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation - NCT01162863-48103
Conditions: Adult - Irritable Bowel Syndrome - Constipation Location: Ann Arbor, MI
- Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients - NCT01056107-55905
Conditions: Irritable Bowel Syndrome Constipation Predominant Location: Rochester, MN
- Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients - NCT00799201-25301
Conditions: Constipation - Analgesia Location: Charleston, WV
- Intestinal Microecology in Chronic Constipation - NCT00934479-85259
Conditions: Chronic Constipation - Irritable Bowel Syndrome Location: Scottsdale, AZ
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-Induced Constipation After Surgery in Inpatient Rehabilitation - NCT00662363-60302
Conditions: Constipation Location: Chicago, IL
- Lubiprostone as a Treatment for Constipation in Parkinson's Disease - NCT00669461-72205
Conditions: Constipation - Parkinson's Disease Location: Little Rock, AR
- Mechanism of Action of Biofeedback Therapy - NCT00988286-52242
Conditions: Constipation - Hyposensitivity - Hypersensitivity Location: Iowa City, IA
- Mechano-physiological Approach to Anorectal Function - NCT00219518-17033
Conditions: Constipation Location: Hershey, PA
- Methylnaltrexone for Opioid-induced Constipation in Cancer Patients - NCT01004393-05401
Conditions: Neoplasms - Constipation - Opioid-Related Disorders Location: Burlington, VT
- Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit - NCT01050595-48075
Conditions: Opioid-induced Constipation Location: Southfield, MI
- Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training - NCT00584571-52242
Conditions: Rectal Hypersensitivity - Irritable Bowel Syndrome-Constipation Location: Iowa City, IA
- Randomized, Double-Blind, Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease - NCT00849784-33612
Conditions: Constipation - Parkinson's Disease Location: Tampa, FL
- Rectal Sensory Training - A Study of Two Techniques - NCT00982839-52242
Conditions: Rectal Hyposensitivity - Constipation Location: Iowa City, IA
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-27599
Conditions: Chronic Idiopathic Constipation Location: Chapel Hill, NC
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-27612
Conditions: Chronic Idiopathic Constipation Location: Raleigh, NC
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-33012
Conditions: Chronic Idiopathic Constipation Location: Hialeah, FL
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-33143
Conditions: Chronic Idiopathic Constipation Location: Miami, FL
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-37205
Conditions: Chronic Idiopathic Constipation Location: Nashville, TN
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-38138
Conditions: Chronic Idiopathic Constipation Location: Germantown, TN
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-48047
Conditions: Chronic Idiopathic Constipation Location: Chesterfield, MI
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-66218
Conditions: Chronic Idiopathic Constipation Location: Shawnee, KS
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-75605
Conditions: Chronic Idiopathic Constipation Location: Longview, TX
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-77479
Conditions: Chronic Idiopathic Constipation Location: Sugarland, TX
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-85206
Conditions: Chronic Idiopathic Constipation Location: Mesa, AZ
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-85741
Conditions: Chronic Idiopathic Constipation Location: Tucson, AZ
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-92801
Conditions: Chronic Idiopathic Constipation Location: Anaheim, CA
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation - NCT01053962-92869
Conditions: Chronic Idiopathic Constipation Location: Orange, CA
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-02301
Conditions: Opioid-induced Constipation Location: Brockton, MA
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-10021
Conditions: Opioid-induced Constipation Location: New York, NY
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-10032
Conditions: Opioid-induced Constipation Location: New York, NY
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-19111
Conditions: Opioid-induced Constipation Location: Philadelphia, PA
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-27103
Conditions: Opioid-induced Constipation Location: Winston Salem, NC
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-27710
Conditions: Opioid-induced Constipation Location: Durham, NC
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-28731
Conditions: Opioid-induced Constipation Location: Flat Rock, NC
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-33137
Conditions: Opioid-induced Constipation Location: Miami, FL
- Study Evaluating Subcutaneous MOA-728 For Treatment of Opioid-Induced Constipation in Patients With Advanced Illness - NCT00672477-33166
Conditions: Opioid-induced Constipation Location: Miami Springs, FL
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|